APA (7th ed.) Citation

J, B., J, Z., X, Z., J, H., W, L., F, X., & R, D. (2025). Effect of AFP and PIVKA-II secretion status on prognosis of advanced hepatocellular carcinoma patients receiving TACE combined with systemic therapy. BMC cancer, 25(1), 1701. https://doi.org/10.1186/s12885-025-15040-9

Chicago Style (17th ed.) Citation

J, Bai, Zhou J, Zhao X, Hua J, Li W, Xiong F, and Ding R. "Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced Hepatocellular Carcinoma Patients Receiving TACE Combined with Systemic Therapy." BMC Cancer 25, no. 1 (2025): 1701. https://doi.org/10.1186/s12885-025-15040-9.

MLA (9th ed.) Citation

J, Bai, et al. "Effect of AFP and PIVKA-II Secretion Status on Prognosis of Advanced Hepatocellular Carcinoma Patients Receiving TACE Combined with Systemic Therapy." BMC Cancer, vol. 25, no. 1, 2025, p. 1701, https://doi.org/10.1186/s12885-025-15040-9.